Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Vaccinations01:51

Vaccinations

45.7K
Overview
45.7K
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

11
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
11
Cancer Vaccines01:30

Cancer Vaccines

547
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
547
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

219
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
219
Causality in Epidemiology01:21

Causality in Epidemiology

1.0K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.0K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.

Mucosal immunology·2026
Same author

Global Epidemiology and Disease Burden of Human Parainfluenza Virus in Adults: A Systematic Review.

Reviews in medical virology·2026
Same author

Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.

Nature communications·2025
Same author

Author Correction: Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025
Same author

Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025
Same author

Human challenge models for vaccine development-strengths, limitations, and expansion into endemic settings: a HIC-Vac meeting report.

Immunotherapy advances·2025

関連する実験動画

Updated: Oct 7, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K

ワクチン学を加速させるための相関値の使用

Peter J M Openshaw1

  • 1National Heart and Lung Institute, Imperial College London, London, UK.

Science (New York, N.Y.)
|January 6, 2022
PubMed
まとめ
この要約は機械生成です。

コレラートとサロゲットは結果を測定するのに有用ですが,限界があります. 科学的な研究における 潜在能力と欠点を理解するには さらに研究が必要である.

さらに関連する動画

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

関連する実験動画

Last Updated: Oct 7, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

科学分野:

  • 生物医学研究
  • 臨床試験
  • 結果の測定

背景:

  • 関連物質と代替物質は研究でよく用いられる.
  • 結果を効率的に測定する上で 潜在的な利点があります
  • しかし,その限界は研究結果の妥当性に影響を与えます.

研究 の 目的:

  • コレラートとサロゲットの有用性について議論する
  • その使用に伴う限界を強調する.
  • 研究設計に注意を払う必要性を強調する.

主な方法:

  • 関連物と代替物を使った研究の文献レビュー.
  • 限界を示す事例を分析する.
  • 統計的および臨床的影響についての議論

主要な成果:

  • 関連や代替は 重要な洞察力を与えてくれます
  • 代替治療と実際の治療の結果には 大きな違いがあります
  • 誤った解釈は誤った結論と 効果のない介入につながります

結論:

  • 価値あるものですが,相関値と代用値は慎重に解釈する必要があります.
  • 研究者は潜在的なバイアスや限界に 気付くべきです
  • 信頼性の高い結果を得るには,実際の臨床結果に対する検証が不可欠です.